newsThe adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine candidate safely…
26 May 2020 | By Hannah Balfour (European Pharmaceutical Review)
The adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine candidate safely induced T cell and antibody responses in 108 adults.